GlassScriptPhysician profile
Li Jin Voepel
NPI 1144294596
$301.52
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $27.50 · 2021: $114 · 2022: $46.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $58.68 | 2019-2020 | |
| Allergan, INC. | $57.08 | 2021 | |
| Zimmer Biomet Holdings, INC. | $28.34 | 2022 | |
| Stryker Corporation | $23.95 | 2021 | |
| Biodelivery Sciences International, INC. | $23.80 | 2020-2021 | |
| Orthogenrx INC. | $21.31 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.18 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.81 | 2019 | |
| Horizon Therapeutics Plc | $16.81 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.75 | 2019 | |
| Abbott Laboratories | $15.83 | 2019 | |
| Electronic Waveform Lab, INC. | $2.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Li Voepel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.